Trader’s Alert – Dyax Corp, Boeing, Tyco

Dyax Corp (NASDAQ:DYAX) shares rose 8.1% to $10.99, their highest price since mid-2004, after positive Phase 1a study results of DX-2930, a treatment for hereditary angioedema attacks. The first-in-human clinical study of DX-2930 met all objectives of assessing safety, tolerability and pharmacokinetics and showed it well tolerated at all dose levels. Pharmacokinetic results demonstrated that…

Read More

Workday Inc (NYSE:WDAY) Earnings Reaction History

Workday, Inc. (NYSE:WDAY) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in WDAY indicates that the price change in the extended hours is…

Read More